Immune modulating human mesenchymal stromal cells (MSCs) have been genetically engineered to express TRAIL, which, when injected intraperitonially into mesothelioma-bearing mice, significantly reduced tumor burden [36]. This evidence concerns the gene TNFSF10 and mesothelioma.